HOME | CONTACT US
Search

 

Biomanufacturing Science & Technology Links

  • Cellulosic Ethanol Future of Sorghum
    The long-term growth of the U.S. sorghum industry depends in part with scientists unraveling paths to produce cellulosic ethanol economically. “We are very excited about the future of energy (forage — whole plant) sorghum as the cellulosic ethanol industry becomes more of a reality in the future,” according to Tim Lust, chief executive officer, National Sorghum Producers (NSP), Lubbock, Texas.
  • Norvatis and Roche to UK: We Might Quit You
    In the Pipeline's Derek Lowe says Novartis and Roche are employing some "hardball negotiating" in their fight with the UK government over drug pricing and clinical trial regulations.
  • Inkjet-like device 'prints' cells right over burns
    Inspired by a standard office inkjet printer, U.S. researchers have rigged up a device that can spray skin cells directly onto burn victims, quickly protecting and healing their wounds as an alternative to skin grafts.
  • Crohn's disease sufferers to benefit from stem cell trial in Galway
    PATIENTS IN the west of Ireland who suffer from the chronic inflammatory condition, Crohn’s disease, will have the opportunity to take part in a cutting-edge clinical trial involving stem cell therapy later this year.
  • Designer Biofuel Crops
    Agrivida is trying to develop plants that help turn themselves into biofuel.
  • Sanofi to invest $200 mln in French biotech plants
    French drugmaker Sanofi-Aventis (SASY.PA) on Wednesday said it would invest 150 million euros ($201.4 million) over four years to build up its biotechnology manufacturing capacities in France.
  • Camelina to Produce 1 Bil Gallons of Biodiesel by 2025
    Researchers at Biomass Advisors say the non-food energy crop will be producing biofuels for the aviation and biodiesel sectors, accounting for 25,000 new jobs, more than $5.5 billion in new revenues and $3.5 billion in new agricultural income for U.S. and Canadian farmers.
  • Elan, Biogen enroll 1st MS trial patient
    Elan Corp. and Biogen Idec enrolled the first of 1,800 patients for a late-stage trial of their multiple sclerosis drug Tysabri.
  • Your Fat May Help You Heal
    It frequently happens in science that what you throw away turns out to be most valuable. It happened to Deepak Nagrath, but not for long. The Rice assistant professor in chemical and biomolecular engineering was looking for ways to grow cells in a scaffold, and he discarded the sticky substance secreted by the cells. Click here to find out more! "I thought it was contamination, so I threw the plates away," said Nagrath, then a research associate at Harvard Medical School.
  • Economics Improve for First Commercial Cellulosic Ethanol Plants
    Many cellulosic fuel producers are working with enzymes to break down tough, inedible plant parts, such as corncobs or switch grass, into simpler sugars that can be fermented to ethanol. Now enzyme companies say they are near to breaking down another tough obstacle: the cost of enzymes that will make the next generation of low-carbon fuels.
  • Thermo Fisher Opens New UK Facility in Cheshire
    The center will be home to mass spectrometry and chromatography operations, as well as a base for advancing therapeutic research tools.
  • Algae advocates praise EPA findings
    The EPA in its Renewable Fuels Standard found that biofuels could have a significant impact on efforts to reduce greenhouse gas emissions when compared with gasoline or diesel fuel. The finding now classifies algae-based biodiesel and renewable diesel as an "advanced biofuel" under U.S. federal guidelines.
  • The Bowels of FDA
    If you’ve wondered about the inner workings of FDA, there’s a new spot on their website that introduces just what FDA does. According to NPR, this site is part of FDA commissioner Margaret Hamburg’s three-phase plan to make the agency more transparent.
  • FDA Approved 26 New Drugs In 2009 Compared With 25 In 2008
    Federal regulators approved 26 new medicines in 2009 compared with 25 in 2008, though several key drugs that were expected to reach store shelves didn't. The U.S. Food and Drug Administration approved 26 first-of-a-kind medicines in 2009, more than in any of the prior four years, according to an analysis by the research firm Washington Analysis.
  • The Ethanol Decade
    The Renewable Fuels Association (RFA) is calling the decade of the 2000’s "the era when biofuels came of age." The ethanol advocacy organization reflects on the last ten years.
  • TOP

     

     
    Home